UBC PiMS Research Group
Pharmacoepidemiology in Multiple Sclerosis Research Group

Project Updates

Association between anti-depressants drugs on the progression of multiple sclerosis.

Researchers found no evidence to suggest that exposure to the antidepressants ‘selective serotonin reuptake inhibitors’ were associated with a delay in MS disability accumulation or progression.

Helen Tremlett to Explore the Role of the gut in Pediatric MS

The Multiple Sclerosis Society of Canada and Multiple Sclerosis Scientific Research Foundation have announced new funding that…

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia